Catalyst Wire Dossier Catalyst Wire Dossier

Orsiro Sirolimus Eluting Coronary Stent System

· Biotronik, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Orsiro Sirolimus Eluting Coronary Stent System, covering 2019-08-01 to 2024-04-26. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions

See pricing